Oligomerix
Latest round
- Series B
Last raised
- Apr 2015
Total raised
- $5.2M
Investors
- 1
About Oligomerix
Founded in 2006 and based in New York, US, Oligomerix Inc. develops drugs targeting tau oligomers, a toxic form of the protein, for diseases like Alzheimer's, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS). In March 2022, Oligomerix, Inc. Oligomerix's primary research and development is on a small-molecule inhibitor named OLX07010. This drug aims to disrupt the initial stages of tau protein aggregation, potentially preventing the progression of the disease through small-molecule drug discovery, immunotherapy approaches, and biomarker assay development for Alzheimer’s disease (AD) and other neurodegenerative disorders. The company uses full-length tau without mutations under conditions that naturally promote oligomer formation, avoiding artificial enhancers like heparin. This methodology closely mimics the natural disease process, enhancing the potential efficacy of its therapeutic candidates.
Who invested in Oligomerix
1 investor across 3 rounds
See all investors in Oligomerix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oligomerix
Who invested in Oligomerix?
Oligomerix has 1 investor on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oligomerix raised?
Oligomerix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Oligomerix last raise money?
Oligomerix's most recent round on record is a Series B, in Apr 2015.
What does Oligomerix do?
Founded in 2006 and based in New York, US, Oligomerix Inc.
Where is Oligomerix headquartered?
Oligomerix is headquartered in White Plains, US.
Which VCs invest in companies like Oligomerix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Oligomerix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Oligomerix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.